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Introduction: Hospitals conduct extensive screening
procedures to assess colonisation of the body surface
of neonates by gram-negative bacteria to avoid
complications like late-onset sepsis. However, the
benefits of these procedures are controversially
discussed. Until now, no systematic review has
investigated the value of routine screening for
colonisation by gram-negative bacteria in neonates for
late-onset sepsis prediction.
Methods and analysis: We will conduct a
systematic review, considering studies of any design
that include infants up to an age of 12 months. We will
search MEDLINE and EMBASE (inception to 2016),
reference lists and grey literature. Screening of titles,
abstracts and full texts will be conducted by two
independent reviewers. We will extract data on study
characteristics and study results. Risk of bias will be
assessed using Quality Assessment of Diagnostic
Accuracy Studies (QUADAS-2) and Quality in
Prognosis Studies (QUIPS) tools. Subgroup analyses
are planned according to characteristics of studies,
participants, index tests and outcome. For quantitative
data synthesis on prognostic accuracy, sensitivity and
specificity of screening to detect late-onset sepsis will
be calculated. If sufficient data are available, we will
calculate summary estimates using hierarchical
summary receiver operating characteristics and
bivariate models. Applying a risk factor approach,
pooled summary estimates will be calculated as relative
risk or OR, using fixed-effects and random-effects
models. I-squared will be used to assess
heterogeneity. All calculations will be performed in
Stata V14.1 (College Station, Texas, USA). The results
will be used to calculate positive and negative
predictive value and number needed to be screened to
prevent one case of sepsis. Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) will be used to assess certainty in
the evidence. The protocol follows the Preferred
Reporting Items for Systematic Review and Meta-
Analysis Protocols (PRISMA-P) guideline.
Ethics and dissemination: This study will not
require ethical approval since it is not carried out in
humans. The systematic review will be published in an
open-access peer-reviewed journal.
Trial registration number: CRD42016036664.
INTRODUCTION
Epidemiological and clinical background
At neonatal intensive care units (NICUs),
late-onset sepsis due to gram-negative patho-
gens is an important cause of neonatal mor-
bidity and mortality.1 The majority of sepsis
episodes (>80%) occurs in preterm neo-
nates.2 Depending on individual factors,
setting and species of bacteria, between 11%
and 46% of very low birth weight infants
(VLBW; <1500 g) are affected.3 Susceptibility
to infection is strongly associated with low
gestational age and low birth weight.4 5
Already in the 1970s, data were published
indicating that infants at NICUs colonised
with gram-negative bacteria were at increased
risk of developing infections subsequently.6
Consecutively, a number of studies investi-
gated the value of routine surface cultures
Strengths and limitations of this study
▪ This systematic review will provide a comprehen-
sive overview on the available evidence regarding
the value of routine screening for colonisation by
gram-negative bacteria in neonates for late-onset
sepsis prediction.
▪ Subgroup analysis will allow investigating the
particular role of setting, birth characteristics,
sampling strategy and cointerventions for test
performance and predictive values
▪ Limitations of the systematic review will arise
from the limitations of the included studies, par-
ticularly regarding consideration and reporting of
confounders in the publications.
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for the prediction of sepsis.7–10 Some hospitals conduct
extensive and costly screening procedures to assess the
colonisation of non-sterile locations of the body surface
of neonates by gram-negative bacteria to avoid complica-
tions like sepsis. In Germany, routine screening for a
selection of pathogens is recommended by the German
Committee on Hospital Infections and Hygiene
(KRINKO). However, the benefits of these screening
procedures are controversially discussed. Moreover, since
microbiological screening is introduced as part of a
bundle of measures (eg, isolation, enhanced barrier
nursing), it is often challenging to measure the particu-
lar effect of screening. Until now, no systematic review
has been published that has investigated the prognostic
value of routine screening for colonisation by gram-
negative bacteria in this at-risk group for the prediction
of late-onset sepsis. Here, we present and explain the
protocol for a respective systematic review that will be
conducted as part of the piloting phase of the Project
on a Framework for Rating Evidence in Public Health
(PRECEPT).11
Prognostic/diagnostic test accuracy and risk factors
According to the Cochrane handbook for systematic reviews of
diagnostic test accuracy studies, prognostic accuracy studies
are using test information to identify patients who will
develop an outcome later on (see http://methods.
cochrane.org/sdt/handbook-dta-reviews). In this sense,
studies that are using screening for gram-negative bac-
teria to predict sepsis are prognostic accuracy studies. In
such studies, the result of a test is compared with the
(clinical) outcome. This differs from the approach of
diagnostic test accuracy studies where the test result is
compared with the result of a reference or ‘gold
standard’ test (figure 1). Therefore, prognostic accuracy
is not a surrogate for patient-important outcomes, as in
diagnostic test accuracy studies.12 This approach has con-
sequences for the design of the studies to be considered.
In contrast to diagnostic test accuracy studies where
cross-sectional study designs are common practice,
cohort studies (prospective or retrospective) are needed
to obtain measures of prognostic accuracy.
A complementary approach to the analysis of the
same data is to conceptualise a positive screening test as
the presence of a risk (or prognostic) factor and to cal-
culate the relative risk of developing the outcome.
However, it is important to consider that the presence of
a high risk ratio (or OR), which is often used to identify
prognostic factors for a certain outcome, does not indi-
cate that the respective risk factor performs well in pre-
dicting this outcome.13–15 Ware showed that a risk factor
strongly associated with a hypothetical outcome (OR
3.58) might have a sensitivity as low as 13% for predict-
ing this outcome. Using the same data, he demonstrated
that an OR of 228 would be needed to reach a sensitivity
of 80%.15 Therefore, it may not be concluded that a risk
factor which is strongly associated with the outcome pro-
vides a basis for an effective preventive measure.
Concepts for systematic reviews of prognostic studies
Various approaches exist regarding the systematic assess-
ment and data synthesis of prognostic studies.16 During
recent years, it has become more and more accepted
that systematic reviews in this field should focus on mea-
sures of association between the predictive/prognostic
factor and the outcome, such as risk ratio, OR or HR, as
well as comprise measures of prognostic accuracy like
sensitivity and specificity (eg, see17). Liu et al18 proposed
Figure 1 Diagnostic versus
prognostic test accuracy.
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to distinguish between systematic reviews of screening
tests and those of diagnostic and prognostic studies. For
screening and diagnosis, they suggested assessing sensi-
tivity and specificity, whereas for questions related to
prognosis the use of HRs was proposed. The Agency for
Healthcare Research and Quality (AHRQ) suggests
using a particular framework for systematic reviews of a
prognostic test.19 In that paper, Rector et al conclude
that it may be informative to assess the accuracy of a
prognostic test by calculating sensitivity, specificity and
predictive values. However, these authors emphasise that
it is critical to consider the time interval between the
test and the occurrence of the outcome.19 In our own
systematic review, we will compute measures of prognos-
tic accuracy and measures of relative risk and compare
the results of these calculations to each other.
Risk of bias
Given the particularities of systematic reviews of prognos-
tic accuracy studies, the question arises whether an estab-
lished risk-of-bias tool exists that captures common
sources of bias in this study design. A number of authors
applied tools that were originally designed to address
risk of bias in diagnostic test accuracy studies.17 20 21
Currently, the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS-2) tool is the most advanced
and widely used tool for the assessment of risk of bias in
diagnostic accuracy studies.22 QUADAS-2 comprises four
domains: patient selection, index test, references stand-
ard and flow and timing. In each domain, questions
related to risk of bias and concerns regarding applicabil-
ity are included.
However, as explained above, there are apparent dif-
ferences in study design between diagnostic and prog-
nostic accuracy studies. At least two sources of bias can
be identified which are important in prognostic accuracy
studies but are not relevant in diagnostic accuracy
studies:
▸ Attrition bias: Owing to the prospective character of
the study design, loss to follow-up of study partici-
pants in the time interval between the conduct of the
screening test and the detection of the outcome
might create attrition bias. Depending on whether or
not rates of loss to follow-up differ between partici-
pants with positive and negative screening test results
(differential vs non-differential loss to follow-up), sen-
sitivity and specificity will change in point estimate or
CI.
▸ Confounding: Confounding will occur if interventions
are delivered to study participants depending on the
result of the screening test. This may influence the
probability of developing the outcome. Again, esti-
mates of sensitivity and specificity might be affected.
Theoretically, it is possible that domain four of the
QUADAS-2 tool (‘flow and timing’) sufficiently captures
attrition bias as well as confounding in the time interval
between screening test and outcome assessment. If this
appears not to be the case, we may test whether the
additional application of a risk of bias tool for risk
factor/prognostic studies such as the Quality in
Prognosis Studies (QUIPS) tool23 is of additional value.
General objective
To assess the usefulness and value of routine screening
for colonisation by gram-negative bacteria performed in
NICUs as predictive measures for late-onset sepsis.
Research question
This systematic review will focus on the following
primary research questions:
1. What is the prognostic value (in terms of sensitivity
and specificity) of routine screening for colonisation
by gram-negative bacteria in neonates at intensive
care units for the prediction of late-onset sepsis?
2. Is colonisation by gram-negative bacteria in neonates
at intensive care units a risk factor for later develop-
ment of late-onset sepsis?
METHODS
This systematic review protocol follows the recommenda-
tions of the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P) guide-
line.24 A copy of the completed PRISMA-P checklist is
attached to this protocol (see online supplementary
appendix 1). This systematic review is registered in the




Studies of any design will be considered. No restrictions
will be made regarding publication language or publica-
tion status.
Participants
Studies that include infants up to an age of 12 months
who are still in a NICU will be considered, irrespective
of the gestational age, birth weight and geographical
region where the study has been conducted.
Study setting




We will search MEDLINE and EMBASE from inception
to 2016, using the DIMDI (Deutsches Institut für
Medizinische Dokumentation und Information) plat-
form. The planned search strategy is shown in box 1.
Reference lists
These searches will be supplemented by ‘snowballing’,
that is, searching for additional studies in the reference
lists of identified original studies and reviews.
Open Access
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Grey literature
We will search for grey literature using the Grey Matters
Light checklist of the Canadian Agency for Drugs and




The study selection process will involve the following
steps:
▸ Screening of titles and abstracts.
▸ Screening of full texts.
At both steps, screening will be conducted by two
independent reviewers. Potential disagreement will be
resolved by discussion or by involving a third reviewer.
We will construct a flow chart to document the selection
process. A list of excluded studies will be prepared,
along with reasons for exclusion.
Data extraction and management
From the included studies, we will extract data on study
characteristics and study results. We will construct a data
extraction form and pilot test it prior to the start of the
review process. Microsoft Office Excel will be used to
construct specific extraction forms. One researcher will
perform data extraction while a second researcher will
independently check for accuracy and details. The fol-
lowing data will be extracted from the original studies:
▸ General study characteristics:
– complete reference of the study (author, year of
publication, title, journal, citation details)
– date of study
– place






– gestational age at birth
– birth weight
– age at screening
– sex
– ethnicity
– length of follow-up (time interval between index
test and outcome assessment)
– comorbidities
– central line use
– need for surgery
▸ Index test characteristics:
– description of sampling device
– sampling time point(s)
– sampling location(s) (eg, umbilicus, tracheal, rectal,
etc)
– sampling intervals (if repetitive)
– processing of specimen
– detected bacteria (species, characterisation)
▸ Outcome:
– definition of sepsis










▸ Measures of association (risk factor approach):
– unadjusted relative risk (or OR)
– adjusted relative risk (or OR)
– confounders considered in adjusted analysis.
Risk of bias assessment
Following the guidance of the PRECEPT framework,11 25
we will use the QUADAS-2 tool to assess risk of bias in the
included individual studies which report measures of
prognostic accuracy.22 Table 1 shows the main compo-
nents of the tool. The results of the risk of bias assessment
will be documented in a separate table for each study
alongside the items of QUADAS-2. For studies reporting
on prognostic measures in terms of a risk factor (or
prognostic study), we will use the QUIPS tool.23 We will
construct bar charts as suggested by Van’t Hooft et al21 to
report summary results of the risk of bias assessments.























#23 #1 OR #2 OR #3
#24 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR
#12 OR #13 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22
#25#14 OR #15 OR #16
#26 #23 AND #24 AND #25
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Subgroup analyses
We will extract detailed information on study partici-
pants, definitions and settings to enable stratified ana-
lysis. In particular, we aim at stratifying the results of the
systematic review and meta-analysis, respectively, accord-
ing to the following variables:
▸ General study characteristics:
– geographic region (Europe vs North America, etc)
– developed country versus developing country
– study period (<1970, 1971–1980, 1981–1990, 1991–
2000, 2001–2010, >2010)
▸ Patient/population characteristics:
– gestational age (<37 weeks vs ≥37 weeks; <32 weeks
vs ≥32 weeks; <26 weeks vs >26 weeks)
– birth weight (<1000 g vs ≥1000 g; <1500 g vs
≥1500 g; <2500 g vs ≥ 2500 g)
– length of follow-up (time interval between index
test and outcome assessment)
▸ Index test characteristics:
– sampling time point(s)
– sampling location(s) (umbilicus vs tracheal, etc)
– species: single species; groups (multidrug-resistant;
difficult to treat)
▸ Outcome characteristics:





– type of ward
▸ Study design.
Statistical analysis
Prognostic accuracy approach: For quantitative data synthe-
sis on prognostic accuracy, we will construct 2×2 tables to
calculate sensitivity and specificity for each included
study. If sufficient comparable data from more than one
study are available, we will perform meta-analysis. To
account for the correlation between sensitivity and speci-
ficity, we will calculate summary estimates using hierarch-
ical summary receiver operating characteristics models26
as well as bivariate models.27 Results will be displayed
graphically using summary receiver operating character-
istic (SROC) plots. We will investigate sources of hetero-
geneity, using subgroup analysis.
Risk factor approach: For quantitative data synthesis
using the risk factor approach, pooled summary esti-
mates will be calculated as relative risk or OR with 95%
CIs, using fixed-effects and random-effects models.
I-squared will be used to assess heterogeneity. If ≥10
Table 1 Structure of the QUADAS-2 tool22





Was a consecutive or random sample of
patients enrolled?
Yes/no/unclear Is there concern that the





unclearWas a case–control design avoided? Yes/no/unclear
Did the study avoid inappropriate exclusions? Yes/no/unclear




2. Index test(s) Were the index test results interpreted without
knowledge of the results of the reference
standard?
Yes/no/unclear Is there concern that the






If a threshold was used, was it prespecified? Yes/no/unclear
Could the conduct or interpretation of the index





Is the reference standard likely to correctly
classify the target condition?
Yes/no/unclear Is there concern that the
target condition as defined
by the reference standard




unclearWere the reference standard results interpreted
without knowledge of the results of the index
test?
Yes/no/unclear
Could the reference standard, its conduct, or its





Was there an appropriate interval between the
index test and reference standard?
Yes/no/unclear
Did all patients receive a reference standard? Yes/no/unclear
Did patients receive the same reference
standard?
Yes/no/unclear
Were all patients included in the analysis? Yes/no/unclear
Could the patient flow have introduced bias? Risk: low/high/
unclear
*Here equivalent to outcome.
Open Access
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studies per outcome are available, publication bias will
be assessed by inspection of funnel plots and applying
Begg’s and Egger’s test.
All calculations will be performed in STATA. The results
of the meta-analysis will be used to calculate positive pre-
dictive value, negative predictive value and number
needed to be screened to prevent one case of sepsis.
Certainty in the evidence (GRADE)
We will use two complementary approaches to assess the
certainty in the evidence (formerly: quality of the evi-
dence) according to the methodology suggested by the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) working group.
Prognostic accuracy approach: We will adopt the GRADE
approach to diagnostic accuracy test reviews for the
purpose of our systematic review on prognostic test
accuracy. The certainty in the evidence will be assessed
for true positives (TP), true negatives (TN), false posi-
tives (FP) and false negatives (FN), as suggested by
GRADE.12 In brief, the application of GRADE will be
conducted as follows:
▸ For each body of evidence on diagnostic studies, all
studies start as ‘high’. ‘True positives’, ‘true negatives’,
‘false positives’ and ‘false negatives’ are defined as
outcomes.
▸ Risk of bias is assessed by the QUADAS-2 tool, and
evidence quality can be downgraded, if necessary.
▸ Thereafter, the other GRADE criteria for downgrad-
ing quality of evidence (inconsistency, indirectness,
imprecision, publication bias) are applied, according
to the approach published by the GRADE working
group.12
Risk factor approach: We will use the GRADE approach
to risk factor/prognostic factor studies. The certainty in
the evidence will be assessed for the outcome late-onset
sepsis according to the GRADE methodology28 as
follows:
▸ For each body of evidence, certainty in the evidence
is initially rated as ‘high’, irrespective of study design.
▸ Risk of bias is assessed by the appropriate risk of bias
tool, and evidence certainty can be downgraded, if
necessary.
▸ Thereafter, the other GRADE criteria for downgra-
ding quality of evidence (inconsistency, indirectness,
imprecision, publication bias) are applied.
▸ Upgrading of the quality of evidence is possible,
according to the criteria introduced by GRADE.
Reporting of this review
The systematic review will be reported according to the
PRISMA guidelines. The PRISMA checklist will be pub-
lished with the report.
DISSEMINATION OF FINDINGS
The resulting systematic review will be published in a
peer-reviewed journal as an open access paper.
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